DerekKevinMarseeMDPhD
Pathology • Sacramento, CADermatopathology, Hematopathology, Anatomic Pathology, Clinical Pathology
President, Diagnostic Pathology Medical Group
Dr. Marsee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3301 C Street
Suite 200-E
Sacramento, CA 95816Phone+1 916-447-6267Fax+1 916-456-5842
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2009 - 2010
Brigham and Women's HospitalFellowship, Hematopathology, 2008 - 2009- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2005 - 2008
Ohio State University College of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2010 - 2026
NV State Medical License 2016 - 2025
MA State Medical License 2009 - 2014- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Dermatopathology
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 35 citationsEffects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapyDaniel H. Y. Shen, Derek K. Marsee, J. Schaap, W. Yang, J-Y Cho
Gene Therapy. 2004-01-01 - 525 citationsATF3 and stress responses.Tsonwin Hai, Curt D. Wolfgang, Derek K. Marsee, Amy E. Allen, Umasundari Sivaprasad
Gene Expression. 1999-01-01 - 41 citationsPodoplanin (D2-40) is a highly effective marker of follicular dendritic cells.Derek K. Marsee, Geraldine S. Pinkus, Jason L. Hornick
Applied Immunohistochemistry & Molecular Morphology. 2009-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
